Study Design Optimization

With our Study Design Optimization you get all the data that you need to outline the best possible design for studies in phase II and III. We point out variables potentially influencing study results with regard to both safety as well as efficacy. By detecting otherwise hidden correlations, you can deliberately select inclusion/exclusion criteria and endpoints. Furthermore, you are capable of identifying the comparator that will grant the greatest potential for differentiation of your product.

Target Groups

  • Project Managers
  • Developers
  • Statisticians
  • Regulatory Affairs
  • Strategic Marketing
  • Market Access

Available Resources​

  • Assessment of all relevant studies (up to hundreds)
  • Assessment of hundreds of clinical abstracts and ClinicalTrials.gov entries

Deliverables

  • Smart Report
  • Underlying Data tables